맘모그래피 시장 : 시장 구조, 예측, 경쟁 동향 및 AI 수익화 아키텍처(2024-2035년)

Report Overview

Mammography remains one of the most established screening infrastructure markets in medical imaging, but it is no longer best understood as a simple equipment replacement category. Dedicated mammography systems, DBT, CEM-capable gantries, service contracts, mammography-specific workflow software, AI, breast biopsy, mobile screening, and supplemental imaging pathways are increasingly connected through the same commercial decision chain.

This Marketstrat® Horizon report analyzes the global mammography market and the broader breast imaging ecosystem from 2024A to 2035F. It separates the Core Mammography Market from the Interventional Breast Pathway and the broader Breast Imaging Ecosystem Opportunity, allowing readers to distinguish the headline system-and-service denominator from adjacent procedure, ultrasound, MRI, access, and workflow value pools.

The central commercial question is no longer only “who sells the mammography gantry?” It is: who controls the breast imaging operating system around the gantry - replacement timing, service, AI, CEM, biopsy, enterprise workflow, provider economics, mobile access, and supplemental imaging routing? The report’s competitive thesis is that durable advantage is shifting from share of gantries toward share of control planes.

This Horizon report is Marketstrat’s in-depth global analysis of mammography and breast imaging market structure. It is built for medical imaging OEM executives, breast health strategy teams, AI and workflow vendors, enterprise imaging platforms, interventional breast technology companies, investors, private equity, distributors, provider networks, and public-sector imaging leaders.

The report covers screening and diagnostic mammography, FFDM, DBT, contrast-enhanced mammography, mammography-specific software and workstations, breast AI, density and risk tools, service contracts, mobile screening, image-guided breast intervention, and supplemental breast imaging pathways. It also evaluates how value migrates across mature replacement markets, access-expansion markets, screening-program markets, China’s two-channel procurement structure, and premium private-network breast imaging pathways.

The report is designed to answer practical commercial questions:

• Where does mammography still grow when gantry hardware is mature?
• Which value pools sit inside the Core Mammography Market, and which sit in adjacent breast imaging pathways?
• How should vendors think about AI monetization when provider-gross value can be larger than vendor-booked software revenue?
• Where is CEM most commercially relevant?
• Which companies control the installed base, service, biopsy pathway, enterprise workflow, AI layer, provider volume, and China/value-tier channels?
• How do regional strategies differ across the U.S., Europe, China, Japan, India, LATAM, and MEA?

Market Snapshot

The global mammography market is structurally mature but strategically active. The gantry pool remains the anchor, yet the most important growth and competitive movement is occurring around the gantry: AI/workflow software, CEM-enabled diagnostic pathways, service retention, interventional breast procedures, breast ultrasound, breast MRI, mobile access infrastructure, and risk-based screening.

The report’s market architecture separates three layers:

Core Mammography Market

Dedicated mammography systems, mammography-specific service, mammography-specific software/workstations, and mammography AI/workflow.

Interventional Breast Pathway

Biopsy systems, localization, image-guided intervention, and related downstream procedure economics.

Breast Imaging Ecosystem Opportunity

The Core Mammography Market plus the Interventional Breast Pathway and breast ultrasound/MRI adjacencies.

This matters because a flat or modestly growing gantry market can still control a larger and faster-moving ecosystem. The report’s framework analysis shows equipment and service as stable, installed-base-heavy pools, while AI/workflow, CEM, breast ultrasound, breast MRI, and biopsy/intervention drive a broader strategic opportunity.

Key Market Trends

1. Mammography is shifting from hardware replacement to ecosystem control

• The strongest competitors are not simply those with the most installed gantries. They are the companies that can defend replacement accounts, attach service, integrate AI and workflow, enable CEM, support biopsy pathways, and keep the breast imaging study inside their operating environment.

2. DBT is becoming baseline in developed markets

• DBT remains strategically important, but in many developed markets it is increasingly a replacement-cycle and premium-standard feature rather than a greenfield growth story. Future differentiation shifts toward workflow, patient experience, AI integration, CEM readiness, dose, acquisition speed, service, and fleet economics.

3. CEM is the most important near-term premium technology overlay

• Contrast-enhanced mammography is not yet a broad screening standard, but it is strategically important for dense-breast workup, diagnostic problem-solving, selected MRI-substitution use cases, CEM-guided biopsy, and premium breast-center positioning. The report treats CEM as a practical near-term overlay rather than a distant frontier technology.

4. AI monetization must be separated from provider economics

• The report distinguishes vendor-net AI/workflow revenue from provider-gross economics. Vendor revenue includes software, OEM-bundled AI, SaaS, enterprise subscriptions, and per-study fees. Provider-gross value includes patient-pay add-ons, workflow productivity, recall management, reimbursement, and downstream throughput. This separation avoids double counting and clarifies who captures value.

5. Breast ultrasound and breast MRI are not inside the core denominator, but they matter commercially

• Supplemental imaging is central to the broader breast imaging pathway. Breast ultrasound and breast MRI are treated as adjacencies rather than core mammography revenue, but they materially shape diagnostic follow-up, dense-breast workflows, high-risk pathways, provider economics, and vendor ecosystem strategy.

6. Regional strategy is not one global adoption curve

• The report frames mammography as a local policy and procurement market with global platform economics. Adoption is shaped by screening age bands, public-program design, insurance coverage, procurement systems, workforce constraints, provider-network structure, and local service capacity.

Competitive Landscape

Marketstrat structures the mammography market into eight competitive clusters because the market is increasingly shaped by control planes rather than a flat OEM ranking.

The report analyzes:

• Systems OEMs / breast health platform incumbents: Hologic, GE HealthCare, Siemens Healthineers, Fujifilm, Canon Medical, Planmed, IMS/Giotto, and selected regional specialists.
• China and value-tier challengers: United Imaging, Wandong, Mindray, Neusoft, Inkon, and regional distributors.
• Breast AI detection and second-reader vendors: ScreenPoint, Lunit, DeepHealth/iCAD, Hologic Genius AI, Vara, Therapixel, CureMetrix, and related screening-AI assets.
• Density, risk, and population-health AI platforms: Lunit/Volpara, Clairity, Densitas, b-rayZ, ScreenPoint/Biomediq, and DeepHealth.
• Enterprise imaging, breast workflow, and AI orchestration platforms: Visage/Pro Medicus, Sectra, Fujifilm Synapse, Intelerad, GE, Siemens, Philips, Mach7, Agfa, Hyland, and related platforms.
• Interventional breast pathway and biopsy ecosystem: Hologic, Mammotome, BD, Merit Medical, Leica/Danaher, GE, Siemens, and related procedure assets.
• Provider networks, mobile access, and telemammography operators: RadNet/DeepHealth, Solis, SimonMed, Mamotest-like models, Krsnaa-like PPP models, and public mobile screening programs.
• Detector, CEM, and photon-counting enabling stack: Siemens, Canon/Redlen, Varex, GE, Hologic, detector suppliers, contrast suppliers, and selected enabling-technology owners.

The report’s competitive conclusion is that no single company controls every layer. Hologic remains the strongest vertical breast-health incumbent, GE and Siemens are credible enterprise and CEM/premium-technology challengers, software and AI platforms increasingly influence reading workflow, and China/value-tier players create a different unit-versus-value competitive tension.

What's Inside

Core model: 2024A–2035F

• Procedure volume
• Installed base
• Annual shipments
• Equipment / gantry revenue
• Service contracts
• Mammography-specific software and workstations
• AI / workflow software
• Core Mammography Market
• Interventional Breast Pathway
• Breast Ultrasound Adjacency
• Breast MRI Adjacency
• Breast Imaging Ecosystem Opportunity

Technology and workflow coverage

• 2D FFDM
• DBT / 3D mammography
• Contrast-enhanced mammography
• Mammography AI detection and second-reader workflows
• Density and risk AI
• Enterprise breast workflow and viewers
• Mobile mammography and telemammography
• Breast ultrasound and breast MRI adjacencies
• Biopsy and interventional breast workflow
• Photon-counting mammography as a scenario/watchlist technology, not a base-case revenue pool

Market-structure views

• Core vs pathway vs ecosystem denominator
• Regional and country market archetypes
• Replacement-cycle dynamics
• Screening-policy and utilization context
• Procurement and tender evidence
• Service and installed-base economics
• CEM and premium overlay strategy
• AI monetization and provider-gross value bridge
• Competitive control-plane analysis

Strategic frameworks

The report applies Marketstrat’s Markintel® framework stack, including M³ Market Momentum Matrix, M-TEM, T-DIC, Solution Adoption & Growth Matrix, ARC-Index, Ecosystem Collaboration Matrix, and Upgrade & Package Ladder. These frameworks translate model outputs into strategic interpretation: which segments deserve investment, where pricing risk is highest, where AI can be monetized, and which technologies are commercially ready versus evidence- or reimbursement-gated.

Geographic coverage

Global, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, plus major countries and named clusters analyzed in the report. The regional model distinguishes mature replacement markets, access-expansion markets, screening-program markets, premium private-network markets, public/value procurement markets, and China’s two-channel structure.

Why This Report?

This report is designed for decision-makers with commercial, product, operational, investment, or strategic exposure to mammography and breast imaging, including:

• Mammography OEM strategy, product, commercial, and corporate development teams
• Breast health platform companies
• AI detection, density/risk, workflow, and orchestration vendors
• Enterprise imaging, PACS, viewer, and reporting platforms
• Breast biopsy, localization, and interventional pathway companies
• Detector, CEM, contrast, and enabling-technology suppliers
• Provider networks, imaging centers, mobile screening operators, and teleradiology platforms
• Investors, banks, private equity, and strategic acquirers
• Distributors and regional channel partners
• Public-sector screening, procurement, and access-infrastructure stakeholders

The report is not only a market-sizing document. It is a strategic map of how value is shifting around mammography: from hardware placement toward service, workflow, AI, CEM, biopsy, enterprise viewing, provider-volume economics, mobile access, and supplemental imaging routing.

Report Details

• Title: Global Mammography Horizon: Market Structure, Forecasts, Competitive Dynamics, and AI Monetization Architecture, 2024A–2035F
• Type: Marketstrat® Horizon Report
• Report ID: MINTH-M02137
• Publication: July 2026
• Forecast Horizon: 2024A–2035F
• Format: PDF digital delivery
• Core Coverage: Mammography systems, FFDM, DBT, CEM, mammography AI/workflow, service and aftermarket, mobile mammography, interventional breast pathway, breast ultrasound, and breast MRI adjacencies
• Geographic Coverage: Global, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, plus major countries and named regional clusters
• License Options: Individual ($4,950), Team ($5,450), Enterprise ($8,950)

Table of Contents

SECTION 1 – EXECUTIVE SUMMARY

• 1.1 EXECUTIVE TAKEAWAYS
• 1.2 THE 25-SECOND READ
• 1.3 GLOBAL MARKET AT-A-GLANCE
• 1.4 WHAT IS STRUCTURALLY CHANGING
• 1.5 REGIONAL ARCHETYPES
• 1.6 COMPETITIVE LANDSCAPE AT-A-GLANCE
• 1.7 IMPLICATIONS-TO-ACTION
• 1.8 SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS

SECTION 2 - RESEARCH & METHODOLOGY

• 2.1 PURPOSE OF THE REPORT
• 2.2 WHAT THIS REPORT IS - AND WHAT IT IS NOT
• 2.3 RESEARCH FOUNDATION AND SOURCE STACK
• 2.4 MARKET DEFINITION AND SEGMENTATION SCHEMA
• 2.6 CORE MARKET SIZING AND FORECASTING METHODOLOGY
• 2.7 AI / WORKFLOW METHODOLOGY
• 2.8 REGIONAL FORECAST METHODOLOGY
• 2.9 COMPETITIVE LANDSCAPE METHODOLOGY
• 2.10 QA, RECONCILIATION, AND LIMITATIONS

SECTION 3 - WORLD MARKET STRUCTURE AND STRATEGIC FRAMEWORKS

• 3.1 STRATEGIC THESIS
• 3.2 GLOBAL MARKET SNAPSHOT
• 3.3 GROWTH DRIVERS
• 3.4 GROWTH CONSTRAINTS
• 3.5 REGIONAL MARKET STRUCTURE
• 3.6 M³ MARKET MOMENTUM MATRIX - REVENUE POOLS
• 3.7 M-TEM - TECHNOLOGY MATURITY SCORING
• 3.8 T-DIC - TECHNOLOGY DIFFUSION AND IMPACT CURVE
• 3.9 SOLUTION ADOPTION & GROWTH MATRIX
• 3.10 ARC-INDEX - COMMERCIALIZATION READINESS
• 3.11 AI MONETIZATION MAP
• 3.12 UPGRADE & PACKAGE LADDER
• 3.13 ECOSYSTEM COLLABORATION MAP
• 3.14 STRATEGIC FRAMEWORKS CLOSING SYNTHESIS

SECTION 4 - COMPETITIVE LANDSCAPE

• 4.1 COMPETITIVE THESIS: MAMMOGRAPHY IS SHIFTING FROM SHARE OF GANTRIES TO SHARE OF CONTROL PLANES
• 4.2 COMPETITIVE ARCHITECTURE: EIGHT CLUSTERS DEFINE THE MARKET
• 4.3 COMPETITIVE CONTROL-PLANE SCORECARD
• 4.4 MARKETSTRAT COMPETITIVE INSIGHT: FIVE WAYS MAMMOGRAPHY COMPETITION IS DIFFERENT
• 4.5 CLUSTER 1 - SYSTEMS OEMS / BREAST HEALTH PLATFORM INCUMBENTS
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • What It Takes to Win in Cluster 1
  • Hologic
  • GE HealthCare
  • Siemens Healthineers
  • Fujifilm
  • Canon Medical
  • Planmed
  • IMS/Giotto
  • Cluster 1 Strategic Takeaways
  • 4.6 CLUSTER 2 - CHINA / VALUE-TIER MAMMOGRAPHY CHALLENGERS
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • What It Takes to Win in Cluster 2
  • United Imaging
  • Wandong
  • Mindray
  • Neusoft
  • Cluster 2 Strategic Takeaways
• 4.7 CLUSTER 3 - BREAST AI DETECTION AND SECOND-READER VENDORS
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • ScreenPoint Medical
  • Lunit / Volpara
  • RadNet / DeepHealth / iCAD
  • Hologic Genius AI
  • Vara
  • Therapixel / MammoScreen
  • CureMetrix
  • Cluster 3 Strategic Takeaways
• 4.8 CLUSTER 4 - DENSITY, RISK, AND POPULATION-HEALTH AI PLATFORMS
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • Lunit / Volpara
  • Clairity
  • Densitas
  • b-rayZ
  • DeepHealth
  • Cluster 4 Strategic Takeaways
• 4.9 CLUSTER 5 - ENTERPRISE IMAGING, BREAST WORKFLOW, AND AI ORCHESTRATION PLATFORMS
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • Visage / Pro Medicus
  • Sectra
  • Fujifilm Synapse
  • Intelerad (GEHC)
  • GE HealthCare Enterprise Workflow
  • Siemens Healthineers Workflow
  • Aidoc aiOS and AI Orchestration Platforms
  • Cluster 5 Strategic Takeaways
• 4.10 CROSS-CLUSTER SYNTHESIS - SOFTWARE CONTROL PLANES
• 4.11 SOFTWARE CLUSTER CLOSING SYNTHESIS
• 4.12 CLUSTER 6 - INTERVENTIONAL BREAST PATHWAY AND BIOPSY ECOSYSTEM
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • Hologic
  • Mammotome
  • BD
  • Merit Medical
  • GE HealthCare
  • Siemens Healthineers
  • Cluster 6 Strategic Takeaways
• 4.13 CLUSTER 7 - PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY OPERATORS
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • RadNet / DeepHealth
  • Solis Mammography
  • SimonMed Imaging
  • Mamotest-like Telemammography Platforms
  • Krsnaa-like PPP Diagnostic Networks
  • Public Mobile Screening Programs
  • Cluster 7 Strategic Takeaways
• 4.14 CLUSTER 8 - DETECTOR, CEM, AND PHOTON-COUNTING ENABLING STACK
  • Cluster Definition
  • Cluster Landscape: How Competition Works
  • GE HealthCare
  • Hologic
  • Siemens Healthineers
  • Canon / Redlen
  • Varex / Direct Conversion
  • Calidar
  • Bayer, Bracco, and Guerbet
  • United Imaging
  • Cluster 8 Strategic Takeaways
• 4.15 CROSS-CLUSTER SYNTHESIS - DOWNSTREAM AND ENABLING CONTROL PLANES
• 4.16 DOWNSTREAM AND ENABLING CONTROL PLANES - CLOSING SYNTHESIS
• 4.17 COMPETITIVE CAPSTONE - FROM VENDOR RANKING TO STRATEGIC CONTROL
  • Key Takeaways
• 4.18 GTM GROWTH–MATURITY MATRIX - MAMMOGRAPHY ECOSYSTEM PLAYERS
  • Framework Definition
  • Competitive Context
  • Strategic Takeaways - GTM Growth–Maturity Matrix
• 4.19 COMPETITIVE EXPOSURE HEATMAP
  • Purpose of the Exposure Heatmap
  • Exposure Heatmap Interpretation
• 4.20 COMPETITIVE STANCE BY PLAYER TYPE
• 4.21 WHERE-TO-WIN COMPETITIVE MAP
• 4.22 COMPETITIVE MOAT DURABILITY LADDER
  • Moat Interpretation
• 4.23 COMPETITIVE PLAYBOOK BY COMPANY CLUSTER
• 4.24 INSIGHTS-TO-ACTION BY STAKEHOLDER
• 4.25 COMPETITIVE SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS
• 4.26 FINAL COMPETITIVE SYNTHESIS

SECTION 5 - REGIONAL AND COUNTRY MARKET ANALYSIS

• 5.1 GLOBAL REGIONAL LENS: MAMMOGRAPHY IS A LOCAL POLICY MARKET WITH GLOBAL PLATFORM ECONOMICS
  • Global Forecast Summary by Region
  • Regional Market Archetypes
• 5.2 NORTH AMERICA REGIONAL ANALYSIS
  • Key Takeaways
  • North America Market Landscape
  • North America Market Snapshot
  • Demand, Screening, and Socioeconomic Context
  • North America Bottom Line
• 5.3 UNITED STATES COUNTRY ANALYSIS
  • U.S. Market Landscape
  • U.S. Market Forecast
  • U.S. Installed Base, Utilization, and Replacement Economics
  • U.S. Screening Policy, Regulation, and Reimbursement Context
  • U.S. Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • U.S. Competitive and Channel Dynamics
  • U.S. Growth Drivers and Constraints
  • U.S. Bottom Line
• 5.4 CANADA COUNTRY ANALYSIS
  • Canada Market Landscape
  • Canada Market Forecast
  • Canada Health-System, Screening, and Procurement Context
  • Canada Installed Base, Utilization, and Replacement Economics
  • Canada Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • Canada Competitive and Channel Dynamics
  • Canada Growth Drivers and Constraints
  • Canada Bottom Line
• 5.5 EUROPE REGIONAL ANALYSIS
  • Key Takeaways
  • Europe Market Landscape
  • Disease, Demographic, and Screening Context
  • Health-System, Reimbursement, and Procurement Context
  • Installed Base, Utilization, and Replacement Economics
  • Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • Competitive and Channel Dynamics
  • Europe Growth Drivers and Constraints
  • Europe Bottom Line
• 5.6 GERMANY COUNTRY ANALYSIS
  • Key Takeaways
  • Germany Market Landscape
  • Germany Market Forecast
  • Germany Disease and Demographic Demand Context
  • Germany Health-System, Reimbursement, and Procurement Context
  • Germany Installed Base, Utilization, and Replacement Economics
  • Germany Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • Germany Competitive and Channel Dynamics
  • Germany Growth Drivers and Constraints
  • Germany Bottom Line
• 5.7 FRANCE COUNTRY ANALYSIS
  • Key Takeaways
  • France Market Landscape
  • France Market Forecast
  • France Disease and Demographic Demand Context
  • France Health-System, Reimbursement, and Procurement Context
  • France Installed Base, Utilization, and Replacement Economics
  • France Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • France Competitive and Channel Dynamics
  • France Growth Drivers and Constraints
  • France Bottom Line
• 5.8 UNITED KINGDOM COUNTRY ANALYSIS
  • Key Takeaways
  • United Kingdom Market Landscape & Forecast
  • United Kingdom Disease and Demographic Demand Context
  • United Kingdom Health-System, Reimbursement, and Procurement Context
  • United Kingdom Installed Base, Utilization, and Replacement Economics
  • United Kingdom Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • United Kingdom Competitive and Channel Dynamics
  • United Kingdom Growth Drivers and Constraints
  • United Kingdom Bottom Line
• 5.9 ITALY COUNTRY ANALYSIS
  • Key Takeaways
  • Italy Market Landscape & Forecast
  • Italy Disease and Demographic Demand Context
  • Italy Health-System, Reimbursement, and Procurement Context
  • Italy Installed Base, Utilization, and Replacement Economics
  • Italy Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • Italy Competitive and Channel Dynamics
  • Italy Growth Drivers and Constraints
  • Italy Bottom Line
• 5.10 REST OF EUROPE NAMED CLUSTERS
  • Cluster Overview
  • Market Forecast by Cluster - ROE
  • Spain / Iberia
  • Nordics
  • Benelux
  • Central and Eastern Europe
  • EUROPE CLOSING SYNTHESIS
• 5.11 ASIA-PACIFIC REGIONAL ANALYSIS
  • Key Takeaways
  • APAC Market Landscape
  • APAC Market Forecast by Revenue Pool / Market View
  • APAC Market Forecast by Country/Regional Cluster
  • APAC Demand, Screening, and Socioeconomic Context
  • APAC Health-System, Reimbursement, and Procurement Context
  • APAC Installed Base, Utilization, and Replacement Economics
  • APAC Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • APAC Competitive and Channel Dynamics
  • APAC Growth Drivers and Constraints
  • APAC Bottom Line
• 5.12 CHINA COUNTRY ANALYSIS
  • Key Takeaways
  • China Market Landscape & Forecast
  • China Disease and Demographic Demand Context
  • China Health-System, Reimbursement, and Procurement Context
  • China Two-Channel Market Structure
  • China Installed Base, Utilization, and Replacement Economics
  • China Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • China Competitive and Channel Dynamics
  • China Growth Drivers and Constraints
  • China Bottom Line
• 5.13 JAPAN COUNTRY ANALYSIS
  • Key Takeaways
  • Japan Market Landscape & Forecast
  • Japan Disease and Demographic Demand Context
  • Japan Health-System, Reimbursement, and Procurement Context
  • Japan Installed Base, Utilization, and Replacement Economics
  • Japan Technology Adoption: DBT, CEM, PCM, AI, and Mobile
  • Japan Competitive and Channel Dynamics
  • Japan Growth Drivers and Constraints
  • Japan Bottom Line
• 5.14 INDIA COUNTRY ANALYSIS
  • Key Takeaways
  • India Market Landscape & Forecast
  • India Disease and Demographic Demand Context
  • India Health-System, Reimbursement, and Procurement Context
  • India Installed Base, Utilization, and Replacement Economics
  • India Technology Adoption: FFDM, DBT, CEM, AI, Breast US, and Mobile
  • India Competitive and Channel Dynamics
  • India Growth Drivers and Constraints
  • India Bottom Line
• 5.15 SOUTH KOREA COUNTRY ANALYSIS
  • Key Takeaways
  • South Korea Market Landscape & Forecast
  • South Korea Disease and Demographic Demand Context
  • South Korea Health-System, Reimbursement, and Procurement Context
  • South Korea Installed Base, Utilization, and Replacement Economics
  • South Korea Technology Adoption: DBT, CEM, AI, Breast US, and Mobile
  • South Korea Competitive and Channel Dynamics
  • South Korea Growth Drivers and Constraints
  • South Korea Bottom Line
• 5.16 AUSTRALIA COUNTRY ANALYSIS
  • Key Takeaways
  • Australia Market Landscape
  • Australia Disease and Demographic Demand Context
  • Australia Health-System, Reimbursement, and Procurement Context
  • Australia Installed Base, Utilization, and Replacement Economics
  • Australia Technology Adoption: DBT, CEM, AI, Breast US/MRI, and Mobile
  • Australia Competitive and Channel Dynamics
  • Australia Growth Drivers and Constraints
  • Australia Bottom Line
• 5.17 REST OF APAC (ROAPAC) NAMED CLUSTERS
  • Cluster Overview
  • Rest of APAC Forecast by Regional Cluster
  • Advanced ROAPAC
  • ASEAN
  • South Asia ex-India
  • Other Emerging APAC
  • ROAPAC Closing Synthesis
• 5.18 LATIN AMERICA REGIONAL ANALYSIS
  • Key Takeaways
  • LATAM Market Landscape & Forecast
  • LATAM Demand, Screening, and Socioeconomic Context
  • LATAM Health-System, Reimbursement, and Procurement Context
  • LATAM Installed Base, Utilization, and Replacement Economics
  • LATAM Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
  • LATAM Competitive and Channel Dynamics
  • LATAM Growth Drivers and Constraints
  • LATAM Bottom Line
• 5.19 BRAZIL COUNTRY ANALYSIS
  • Key Takeaways
  • Brazil Market Landscape & Forecast
  • Brazil Demand and Screening Context
  • Brazil Health-System, Reimbursement, and Procurement Context
  • Brazil Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
  • Brazil Competitive and Channel Dynamics
  • Brazil Growth Drivers and Constraints
  • Brazil Bottom Line
• 5.20 MEXICO COUNTRY ANALYSIS
  • Key Takeaways
  • Mexico Market Landscape & Forecast
  • Mexico Demand and Screening Context
  • Mexico Health-System, Reimbursement, and Procurement Context
  • Mexico Installed Base, Utilization, and Replacement Economics
  • Mexico Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
  • Mexico Competitive and Channel Dynamics
  • Mexico Growth Drivers and Constraints
  • Mexico Bottom Line
• 5.21 REST OF LATAM NAMED CLUSTER
  • Cluster Overview
  • Rest of LATAM Forecast by Revenue Pool/Market View
  • Rest of LATAM Market Structure and Strategic Readiness
  • Rest of LATAM Bottom Line
• 5.22 MIDDLE EAST & AFRICA REGIONAL ANALYSIS
  • Key Takeaways
  • MEA Market Landscape
  • MEA Forecast by Revenue Pool / Market View
  • MEA Demand, Screening, and Socioeconomic Context
  • MEA Health-System, Reimbursement, and Procurement Context
  • MEA Installed Base, Utilization, and Replacement Economics
  • MEA Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
  • MEA Competitive and Channel Dynamics
  • MEA Growth Drivers and Constraints
  • MEA Bottom Line
• 5.23 GCC NAMED CLUSTER
  • Cluster Overview
  • GCC Forecast by Revenue Pool / Market View
  • GCC Market Structure and Strategic Readiness
  • GCC Bottom Line
• 5.24 SOUTH AFRICA COUNTRY ANALYSIS
  • Key Takeaways
  • South Africa Market Landscape & Forecast
  • South Africa Demand and Screening Context
  • South Africa Health-System, Reimbursement, and Procurement Context
  • South Africa Installed Base, Utilization, and Replacement Economics
  • South Africa Technology Adoption: Mammography, Ultrasound, Biopsy, AI, and Mobile
  • South Africa Competitive and Channel Dynamics
  • South Africa Growth Drivers and Constraints
  • South Africa Bottom Line
• 5.25 REST OF MEA ACCESS-INFRASTRUCTURE CLUSTER
  • Cluster Overview
  • Rest of MEA Forecast
  • Rest of MEA Market Structure and Strategic Readiness Rest of MEA Bottom Line

SECTION 5 CLOSING SYNTHESIS - REGIONAL STRATEGY IMPLICATIONS